A detailed history of Exodus Point Capital Management, LP transactions in Liquidia Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 29,743 shares of LQDA stock, worth $345,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,743
Holding current value
$345,613
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$8.9 - $14.11 $264,712 - $419,673
29,743 New
29,743 $297,000
Q2 2023

Aug 10, 2023

SELL
$6.63 - $9.9 $311,311 - $464,854
-46,955 Reduced 38.43%
75,216 $590,000
Q1 2023

May 11, 2023

BUY
$5.72 - $7.91 $698,818 - $966,372
122,171 New
122,171 $844,000
Q2 2022

Aug 19, 2022

SELL
$3.37 - $7.55 $482,493 - $1.08 Million
-143,173 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$5.14 - $7.38 $667,464 - $958,344
129,857 Added 975.2%
143,173 $1.03 Million
Q4 2021

Feb 11, 2022

BUY
$2.71 - $5.17 $36,086 - $68,843
13,316 New
13,316 $65,000
Q3 2021

Nov 15, 2021

SELL
$2.28 - $2.95 $49,569 - $64,135
-21,741 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$2.51 - $3.11 $54,569 - $67,614
21,741 New
21,741 $62,000
Q1 2021

May 17, 2021

SELL
$2.42 - $3.6 $30,758 - $45,756
-12,710 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.6 - $5.79 $33,046 - $73,590
12,710 New
12,710 $37,000
Q3 2020

Nov 16, 2020

SELL
$4.34 - $8.28 $48,469 - $92,471
-11,168 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$4.86 - $11.44 $80,224 - $188,840
-16,507 Reduced 59.65%
11,168 $94,000
Q1 2020

May 15, 2020

BUY
$3.31 - $7.15 $91,604 - $197,876
27,675 New
27,675 $130,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $748M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.